Lymphoma Australia Crossword #2

12345678910
Across
  1. 2. Low levels of immunoglobulins that may cause patients to experience recurrent infections. This may be treated with Intravenous Immunoglobulin.
  2. 6. A side effect of some treatments that can cause numbness and tingling in the hands and feet, often associated with Platinum-based chemotherapy.
  3. 8. A type of approval for medications based on early phase clinical trials (early phase referring to trials in stage 1 + 2)
  4. 9. Acalabrutinib, Ibrutinib and Zanubrutinib are all types of what medications?
  5. 10. The staging system used in Chronic Lymphocytic Leukaemia.
Down
  1. 1. An interleukin-6 (IL-6) receptor antagonist that is used to treat Cytokine Release Syndrome.
  2. 3. A CD20-directed CD3 T-cell engager, bispecific antibody, though not yet on the PBS, it is now approved by the Therapeutic Goods Administration (TGA) in Australia in 2nd line relapsed, refractory DLBCL.
  3. 4. Filgrastim is a non-pegylated human granulocyte colony-stimulating factor (G-CSF) is often utilised for what low blood cell count?
  4. 5. When an individual’s Lymphoma is no longer responding to treatment.
  5. 7. Fill in the blank: Chimeric _ Receptor T-cell Therapy